The rise in pancreatic cancer diagnoses can be attributed to detection of smaller, early-stage endocrine cancer, and not an increase in pancreatic adenocarcinoma, according to a study published Nov.

The rising incidence of pancreatic cancer among young Americans may largely reflect previously undetected cases not a true rise in occurrence, experts say.

(“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic intended to improve the outcomes and quality of life for patients, ...

WEST PALM BEACH, Fla. (CBS12) — Eric Borden, a pancreatic cancer survivor, is using his personal experience to raise ...

A recent analysis of pancreatic cancer data in young adults (aged 15–39) has found that although there is an increase in ...

About Cardiff Oncology, Inc. Cardiff Oncology is a clinical ... ongoing and planned investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC) ...

In the study, 34 patients with stage 4 metastatic pancreatic cancer were randomized ... the UI team also included cancer ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

A team of researchers explored the potential benefits of an investigational hand therapy intervention for patients with pancreatic cancer undergoing ... With the established benefits of exercise in ...

What we did here is look at tissue in 3D and then map the genetic alterations onto that 3D model,” explained Laura Wood, M.D., Ph.D., Associate Professor of Pathology and Oncology at the Johns Hopkins ...